Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Min

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Yonsei Medical Journal|September 1, 1990
Male breast cancer--a 20-year review of 16 cases at Yonsei UniversityH C Chung, E H Koh, J K Roh, et al.
International Journal of Immunopharmacology|January 1, 1990
Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents: a preliminary reportJ K Youn, B S Kim, J S Min, et al.
Yonsei Medical Journal|June 1, 1990
Comparison of adjuvant radiotherapy and chemoradiotherapy following surgery in stage IE and IIE primary gastrointestinal tract non-Hodgkin's lymphomaH C Chung, J K Roh, E H Koh, et al.
Yonsei Medical Journal|June 1, 1991
Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancerH C Chung, D L Kim, E H Koh, et al.
International Journal of Molecular Medicine|August 10, 2000
Tissue urokinase-type plasminogen activator receptor levels in breast cancerS J Gong, S Y Rha, H C Chung, et al.
Breast Cancer Research and Treatment|August 7, 1998
Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patientsH C Chung, S Y Rha, J O Park, et al.
Yonsei Medical Journal|June 1, 1992
Should all the N3 lymph nodes group metastasis be regarded as distant metastasis (M1) in curatively resected gastric cancer?H C Chung, H Y Lim, E H Koh, et al.
International Journal of Immunopharmacology|January 1, 1987
Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents. Differential effect on natural killer cell and antibody-dependent cellular cytotoxicityJ K Youn, B S Kim, J S Min, et al.
Journal of Korean Medical Science|June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissuesJ H Kim, J J Choi, S H Noh, et al.
American Journal of Clinical Oncology|November 5, 1997
Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancerJ O Park, H C Chung, J Y Cho, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Yonsei Medical Journal|September 1, 1990
Male breast cancer--a 20-year review of 16 cases at Yonsei UniversityH C Chung, E H Koh, J K Roh, et al.
International Journal of Immunopharmacology|January 1, 1990
Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents: a preliminary reportJ K Youn, B S Kim, J S Min, et al.
Yonsei Medical Journal|June 1, 1990
Comparison of adjuvant radiotherapy and chemoradiotherapy following surgery in stage IE and IIE primary gastrointestinal tract non-Hodgkin's lymphomaH C Chung, J K Roh, E H Koh, et al.
Yonsei Medical Journal|June 1, 1991
Expression of prognostic factors (EGFR, ER) by immunohistochemical staining method in male breast cancerH C Chung, D L Kim, E H Koh, et al.
International Journal of Molecular Medicine|August 10, 2000
Tissue urokinase-type plasminogen activator receptor levels in breast cancerS J Gong, S Y Rha, H C Chung, et al.
Breast Cancer Research and Treatment|August 7, 1998
Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patientsH C Chung, S Y Rha, J O Park, et al.
Yonsei Medical Journal|June 1, 1992
Should all the N3 lymph nodes group metastasis be regarded as distant metastasis (M1) in curatively resected gastric cancer?H C Chung, H Y Lim, E H Koh, et al.
International Journal of Immunopharmacology|January 1, 1987
Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents. Differential effect on natural killer cell and antibody-dependent cellular cytotoxicityJ K Youn, B S Kim, J S Min, et al.
Journal of Korean Medical Science|June 1, 1993
Comparison of p53 gene mutations in paired primary and metastatic gastric tumor tissuesJ H Kim, J J Choi, S H Noh, et al.
American Journal of Clinical Oncology|November 5, 1997
Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancerJ O Park, H C Chung, J Y Cho, et al.
Pageof 8